Topical administration of cinnamic aldehyde accelerates wound healing in diabetic mice by activation of Nrf2 pathway
Basic Medicine|更新时间:2026-01-09
|
Topical administration of cinnamic aldehyde accelerates wound healing in diabetic mice by activation of Nrf2 pathway
Journal of Third Military Medical UniversityVol. 39, Issue 19, Pages: 1906-1912(2017)
作者机构:
400037 重庆, 第三军医大学新桥医院内分泌科
作者简介:
基金信息:
the General Program of National Natural Science Foundation of China(81471039);the National Natural Science Foundation of Young Scholars of China(81500647);the Project of Basic Science and Frontier Technology of Chongqing(CSTC2016jcyjA1584);the Project of Diabetic Research for Young Doctors(2015)
Leiqin CAI, Wenjie LI, Min LONG, et al. Topical administration of cinnamic aldehyde accelerates wound healing in diabetic mice by activation of Nrf2 pathway[J]. Journal of Third Military Medical University, 2017, 39(19): 1906-1912.
DOI:
Leiqin CAI, Wenjie LI, Min LONG, et al. Topical administration of cinnamic aldehyde accelerates wound healing in diabetic mice by activation of Nrf2 pathway[J]. Journal of Third Military Medical University, 2017, 39(19): 1906-1912. DOI: 10.16016/j.1000-5404.201704153.
Topical administration of cinnamic aldehyde accelerates wound healing in diabetic mice by activation of Nrf2 pathway
To determine the effect of topical administration of cinnamic aldehyde (CA) on wound healing in diabetic mice
and investigate the underlying mechanism.
Methods
2
A total of 8 Nrf2
+/+
and 8 Nrf2
-/-
male hairless SKH-1 mice (8 weeks old) were intraperitoneally injected with streptozotocin (STZ
50 mg/kg) for 5 consecutive days to establish diabetic model. The mice were randomly divided into 4 groups: control group of Nrf2
+/+
mice (Nrf2
+/+
Veh)
CA treatment group of Nrf2
+/+
mice (Nrf2
+/+
CA)
control group of Nrf2
-/-
mice (Nrf2
-/-
Veh)
and CA treatment group of Nrf2
-/-
mice (Nrf2
-/-
CA) (
n
=4 for each group). In 4 weeks after STZ injection
2 full-thickness wounds (6 mm in size) were made on the back of the mice. From the day after surgery
Nrf2
+/+
CA and Nrf2
-/-
CA groups received topical administration with 20 μL 4 μmol/L CA diluted by polyethylene glycol 400 (PEG 400) every other day until skin tissues were harvested at the 14th day post-surgery
and Nrf2
+/+
Veh and Nrf2
-/-
Veh groups were given 20 μL PEG 400 as control. Meanwhile
the wound closure rates were monitored and assessed in 2 weeks post-surgery. The expression levels of Nrf2
downstream target protein HO-1
and 8-oxo-2'-deoxyguanosine (8-oxo-dG
a sensitive parameter for oxidative stress) in the skin of each group were assessed by immunohistochemistry.
Results
2
Topical administration of CA significantly accelerated the wound healing of Nrf2
+/+
diabetic mice (
P
<
0.05)
but had no such effect on the Nrf2
-/-
CA group (
P
>
0.05). Moreover
the expression levels of Nrf2 (2.42±0.29
vs
7.42±0.73
P
<
0.05) and HO-1 (5.92±0.36
vs
8.88±0.53
P
<
0.05) were increased
while the level of 8-oxo-dG (9.46±0.28
vs
8.46±0.23
P
<
0.05) was decreased at the wound site after CA treatment in Nrf2
+/+
diabetic mice. However
in the Nrf2
-/-
diabetic mice
CA treatment showed no effect on the expression levels of Nrf2
HO-1 and 8-oxo-dG.
Conclusion
2
Topically application of CA promotes diabetic wound healing
via
activation of Nrf2 pathway and alleviation of oxidative damage.
关键词
Keywords
references
SCHAPER N C, APELQVIST J, BAKKER K. Reducing lower leg amputations in diabetes: a challenge for patients, healthcare providers and the healthcare system[J]. Diabetologia, 2012, 55(7): 1869-1872.DOI:10.1007/s00125-012-2588-z.
CAVANAGH P R, LIPSKY B A, BRADBURY A W, et al . Treatment for diabetic foot ulcers[J ] . Lancet, 2005, 366(9498): 1725-1735.DOI:10.1016/S0140-6736(05)67699-4.
ELDOR R, RAZ I, BEN Y A, et al . New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies[J ] . Diabet Med, 2004, 21(11): 1161-1173.DOI:10.1111/j.1464-5491.2004.01358.x.
SCHAFER M, WERNER S. Oxidative stress in normal and impaired wound repair[J]. Pharmacol Res, 2008, 58(2): 165-171.DOI:10.1016/j.phrs.2008.06.004.
JARAMILLO M C, ZHANG D D. The emerging role of the Nrf2-Keap1 signaling pathway in cancer[J]. Genes Dev, 2013, 27(20): 2179-2191.DOI:10.1101/gad.225680.113.
LONG M, ROJO DE LA VEGA M, WEN Q, et al . An Essential Role of NRF2 in Diabetic Wound Healing[J ] . Diabetes, 2016, 65(3): 780-793.DOI:10.2337/db15-0564.
SOARES M A, COHEN O D, LOW Y C, et al . Restoration of Nrf2 Signaling Normalizes the Regenerative Niche[J ] . Diabetes, 2016, 65(3): 633-646.DOI:10.2337/db15-0453.
LI W J, CAI L Q, LONG M, et al . Cinamic aldehyde improves fibroblasts migration under hyperglycemic condition and its underlying mechanism[J ] . J Third Mil Med Univ, 2017, 39(5): 423-429. DOI:10.16016/J.10005404.201608082.
PHATAK U P, PASHANKAR D S. Role of Polyethylene Glycol in Childhood Constipation[J]. Clinical Pediatrics, 2014, 53(10): 927-932.DOI:10.1177/0009922813505699.
DINKOVA-KOSTOVA A T, JENKINS S N, FAHEY J W, et al . Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts[J ] . Cancer Letters, 2006, 240(2): 243-252.DOI:10.1016/j.canlet.2005.09.012.
FRANKLIN S J, DICKINSON S E, KARLAGE K L, et al . Stability of sulforaphane for topical formulation[J ] . Drug Dev Ind Pharm, 2014, 40(4): 494-502.DOI:10.3109/03639045.2013.768634.
ZHENG H, WHITMAN S A, WU W, et al . Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy[J ] . Diabetes, 2011, 60(11): 3055-3066.DOI:10.2337/db11-0807.
LONG M, TAO S, ROJO DE LA VEGA M, et al . Nrf2-Dependent Suppression of Azoxymethane/Dextran Sulfate Sodium-Induced Colon Carcinogenesis by the Cinnamon-Derived Dietary Factor Cinnamaldehyde[J ] . Cancer Prev Res(phila), 2015, 8(5): 444-454.DOI:10.1158/1940-6207.CAPR-14-0359.
KARRI V V, KUPPUSAMY G, TALLURI S V, et al . Current and emerging therapies in the management of diabetic foot ulcers[J ] . Curr Med Res Opin, 2016, 32(3): 519-542.DOI:10.1185/03007995.2015.1128888.
JEFFCOATE W J, HARDING K G. Diabetic foot ulcers[J]. Lancet, 2003, 361(9368): 1545-1551.DOI:10.1016/S0140-6736(03)13169-8.
HAYES J D, DINKOVA-KOSTOVA A T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism[J]. Trends Biochem Sci, 2014, 39(4): 199-218.DOI:10.1016/j.tibs.2014.02.002.
KNATKO E V, IBBOTSON S H, ZHANG Y, et al . Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans[J ] . Cancer Prev Res (Phila), 2015, 8(6): 475-486.DOI:10.1158/1940-6207.CAPR-14-0362.
KERNS M L, GUSS L, FAHEY J, et al . Randomized, split-body, single-blinded clinical trial of topical broccoli sprout extract: Assessing the feasibility of its use in keratin-based disorders[J ] . J Am Acad Dermatol, 2017, 76(3): 449-453.DOI:10.1016/j.jaad.2016.10.009.
FRIEDMAN M, KOZUKUE N, HARDEN L A. Cinnamaldehyde content in foods determined by gas chromatography-mass spectrometry[J]. J Agric Food Chem, 2000, 48(11): 5702-5709.DOI: 10.1021/jf000585g.
Effect and mechanism of dimethyl fumarate on septic cardiomyopathy in mice
Protective effects of agmatine on oxidative stress induced by LPS in RAW264.7 cells
Resveratrol alleviates cerebral ischemia-reperfusion injury in rats
Protective effect of genistein on oxidative stress-induced injuries of human vascular endothelial cells
Role and mechanism of SIRT3 in oxidative stress and mitochondrial biogenesis in alveolar type II cells
Related Author
闵卫翔
陈学均
马德祥
刘宇
刘书婷
史梦曦
侯凤艳
罗莉
Related Institution
Department of Human Anatomy, Anhui Medical University
Laboratory of Stem Cell and Tissue Engineering, Chongqing Medical University
Institute of Field Surgery, Daping Hospital, Army Medical University
Department of Geriatrics and Special Service Medicine, First Affiliated Hospital(Southwest Hospital), Army Medical University (Third Military Medical University)